PMID- 10340953 OWN - NLM STAT- MEDLINE DCOM- 19990707 LR - 20131121 IS - 1044-1549 (Print) IS - 1044-1549 (Linking) VI - 20 IP - 6 DP - 1999 Jun TI - Dissociation of airway hyperresponsiveness from immunoglobulin E and airway eosinophilia in a murine model of allergic asthma. PG - 1326-34 AB - Nonspecific airway hyperresponsiveness (AHR) is a hallmark of human asthma. Both airway eosinophilia and high serum levels of total and antigen-specific immunoglobulin E (IgE) are associated with AHR. It is unclear, however, whether either eosinophilia or increased IgE levels contribute directly to, or predict, the development of AHR. Investigations conducted with various murine models of asthma and different mouse strains have resulted in conflicting evidence about the roles that IgE and airway eosinophilia play in the manifestation of AHR. We show that systemic priming with ovalbumin (OVA) in alum, followed by a single day of OVA aerosol challenge, is sufficient to induce AHR, as measured by increased pulmonary resistance in response to intravenously delivered methacholine in BALB/c, but not C57BL/6 or B6D2F1, mice. This was observed despite the fact that OVA-challenged BALB/c mice had less airway eosinophilia and smaller increases in total IgE than either C57BL/6 or B6D2F1 mice, and had less pulmonary inflammation and OVA-specific IgE than B6D2F1 mice. We conclude that airway eosinophilia, pulmonary inflammation, and high serum levels of total or OVA-specific IgE are all insufficient to induce AHR in C57BL/6 and B6D2F1 mice, whereas BALB/c mice demonstrate AHR in the absence of airway eosinophilia. These data confirm that the development of AHR is genetically determined, not only in naive mice, but also in actively immunized ones, and cannot be predicted by levels of airway eosinophilia, pulmonary inflammation, total IgE, or antigen-specific IgE. FAU - Wilder, J A AU - Wilder JA AD - Department of Pathology, University of New Mexico, Albuquerque, New Mexico 87131, USA. jwilder@salud.unm.edu FAU - Collie, D D AU - Collie DD FAU - Wilson, B S AU - Wilson BS FAU - Bice, D E AU - Bice DE FAU - Lyons, C R AU - Lyons CR FAU - Lipscomb, M F AU - Lipscomb MF LA - eng GR - 5 P50 HL56384/HL/NHLBI NIH HHS/United States GR - 5T32 8HL 07733/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Am J Respir Cell Mol Biol JT - American journal of respiratory cell and molecular biology JID - 8917225 RN - 0 (Bronchoconstrictor Agents) RN - 0W5ETF9M2K (Methacholine Chloride) RN - 37341-29-0 (Immunoglobulin E) RN - 9006-59-1 (Ovalbumin) SB - IM MH - Animals MH - Asthma/genetics/*immunology MH - Bronchoconstrictor Agents/pharmacology MH - Cell Movement MH - Disease Models, Animal MH - Dose-Response Relationship, Drug MH - Eosinophilia/*immunology MH - Humans MH - Immunoglobulin E/*immunology MH - Inflammation MH - Lung/immunology/pathology MH - Methacholine Chloride/pharmacology MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Ovalbumin/immunology MH - Respiratory Hypersensitivity/*immunology EDAT- 1999/05/26 00:00 MHDA- 1999/05/26 00:01 CRDT- 1999/05/26 00:00 PHST- 1999/05/26 00:00 [pubmed] PHST- 1999/05/26 00:01 [medline] PHST- 1999/05/26 00:00 [entrez] AID - 10.1165/ajrcmb.20.6.3561 [doi] PST - ppublish SO - Am J Respir Cell Mol Biol. 1999 Jun;20(6):1326-34. doi: 10.1165/ajrcmb.20.6.3561.